Brief: Kancera Signs Research And Option Agreement With Grünenthal

Novakand Pharma AB

03/12/2018 11:14

Dec 3 (Reuters) - Kancera AB  KANC.ST :
    * SIGNS RESEARCH AND OPTION AGREEMENT WITH GRÜNENTHAL
    * KANCERA TO GET UPFRONT PAYMENT OF ABOUT SEK 3 MILLION,
MILESTONE
PAYMENTS WHICH AMOUNT TO ABOUT SEK 340 MILLION, AND ROYALTIES

Source text for Eikon:  ID:nWkr6w3xjB 
Further company coverage:  KANC.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))